Lv41
590 积分 2024-11-19 加入
Understanding the activation mechanism of GLP-1R/GIPR by dual agonist Tirzepatide via molecular dynamics and protein-peptide binding
31分钟前
待确认
GLP-1R agonists: recent advances, current gaps, and future challenges
6天前
已完结
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
9天前
已完结
A Comprehensive Review of PCSK9 Inhibitors
2个月前
已完结
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
2个月前
已完结
The changing landscape of atherosclerosis
2个月前
已完结
Global epidemiology of dyslipidaemias
2个月前
已完结
An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels In Vivo
3个月前
已完结
Molecular basis of PCSK9 function
3个月前
已完结
An update on inclisiran for the treatment of elevated LDL cholesterol
3个月前
已完结
皖公网安备34019202002308
